Biotech Capital Markets Highlights: Transactions 2X Over 2023

Week Ending August 16th, 2024:

• Biotech: 4 Transactions (1 IPO, 2 Follow-Ons, and 1 RD) totaling just over $500 Million

• Med Tech: 1 Transaction (1 Follow-On) totaling just over $50 Million

2024 YTD:

• 195 Biotech transactions totaling just over $32 Billion v. 2023 YTD: 6 Med Tech transactions just over $16 Billion

• 9 Med Tech transactions totaling just over $1 Billion v. 2023 YTD: 6 Med Tech transactions totaling just over $400 Million

Private Transactions:

• Biotech: 170 US Transactions / 68 European Transactions

• Med Tech: 108 US Transactions / 40 European Transactions

Recent Deals:

• Crown Laboratories acquired Revance for $924M or $6.66/share

• Pharmacosmos acquired G1 Therapeutics for $405M or $7.15/share

• Otsuka Pharmaceutical acquired Jnana Therapeutics $800M